Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection.
Lancet Reg Health West Pac
; 33: 100759, 2023 Apr.
Article
in En
| MEDLINE
| ID: mdl-37090240
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Lancet Reg Health West Pac
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: